About Explogen

Explogen LLC (EXG) is a small Ukrainian enterprise formed in mid-2019 in Lviv, which deploys biological approaches to access the chemical diversity encrypted within bacterial genomes. The company is organized and led by researchers with the in-depth experience in synthetic biology of microorganisms, genomics and bioinformatics. Explogen represents in Ukraine a unique case of research-intensive biotech startup. Its main asset is team of experienced researchers who honed their skills in top institutions - such as Universities of Saarland and Cambridge, Harvard University, Boston University. Their decision to work in home country is driven by the idea to develop a world-class research program, which would contribute to positive changes in Ukrainian science and society.

Primarily, Explogen focuses on Actinobacteria encrypted chemical diversity as a main internal research project. Our ultimate goal is to provide sustainable access to new biologically active natural products by applying efficient cloning and heterologous expression approach. However, with expanding our expertise to new microorganisms and building up a set of universal synthetic biology tools, we are now offering strain engineering and cloning of large chromosomal fragments as services.

Explogen is also aiming to change the view on biotech possibilities in Ukraine. One of our missions is to mentor a new generation of genetics, molecular biology and biotechnology specialists in Ukraine by providing access to front-line technologies, equipment and expertise. Ukraine boasts a wealth of talented young people, who have limited opportunities to realize themselves as biotech professionals locally. Explogen serves as an example of such opportunities for young scholars from local universities.